ADHD Medication Waiting Lists: What Happens After Diagnosis?
ADHD support and treatment
An ADHD diagnosis can provide validation and greater understanding. However, for people considering medication, diagnosis may be followed by another substantial wait before treatment begins.
Receiving an ADHD diagnosis can bring relief, clarity and a better understanding of lifelong experiences. However, diagnosis is not always the end of the journey.
If medication is recommended, some people may experience a further wait before they can begin treatment and medication titration.
How long are people waiting?
As of July 2026, Psychiatry UK’s published NHS Right to Choose estimates indicate waiting times of approximately:
- 18–20 weeks for an adult ADHD assessment.
- 44–52 weeks for medication titration following assessment.
These figures relate specifically to Psychiatry UK and are estimates rather than national waiting times. However, they demonstrate that some people may wait considerably longer for medication than they did for their diagnostic assessment.
Why doesn’t medication begin immediately after diagnosis?
An ADHD diagnosis does not automatically mean medication will be prescribed. Medication is one treatment option, and the decision should consider the person’s needs, preferences, medical history, circumstances and level of functional difficulty.
Before medication is initiated, an appropriately qualified prescriber will usually need to:
Baseline checks may include blood pressure, pulse, height and weight. An ECG, blood tests or further medical advice may also be needed where clinically indicated.
Sleep, appetite, cardiovascular health, substance use and the potential risk of medication misuse or diversion may also need to be considered. These checks are an important part of prescribing ADHD medication safely.
What is ADHD medication titration?
Titration is the process of gradually introducing and adjusting medication to identify a dose that provides meaningful benefit while minimising side effects.
During titration, the clinical team may monitor:
- Attention, impulsivity and restlessness.
- Emotional or behavioural changes.
- Sleep and appetite.
- Blood pressure, pulse and weight.
- Side effects and treatment tolerability.
- Functioning at home, work, school or university.
- The person’s experience of whether the medication is helping.
Psychiatry UK reports that its titration process usually takes approximately 12–16 weeks once it has started, although the process may take longer for some people. This is separate from the waiting period before titration begins.
National clinical guidance
What does NICE recommend for ADHD?
NICE guideline NG87 recommends developing a shared and personalised treatment plan that considers the person’s needs, preferences, circumstances, strengths and coexisting conditions.
For adults, NICE recommends offering medication when ADHD symptoms continue to cause significant impairment in at least one area of life after environmental modifications have been considered and implemented.
Non-pharmacological treatment should also be considered when an adult:
- Makes an informed choice not to take medication.
- Has difficulty adhering to medication.
- Cannot tolerate medication.
- Does not experience sufficient benefit from medication.
Where medication has helped but significant difficulties remain, NICE recommends considering a combination of medication and structured psychological support. This support should focus on ADHD and may include cognitive behavioural therapy.
For children and young people, NICE advises providing ADHD-focused information and support to parents or carers and involving the child’s school or educational setting. Medication may be considered for children aged five and over when symptoms continue to cause significant impairment despite appropriate environmental modifications.
NICE also recommends regularly monitoring the effectiveness and adverse effects of ADHD medication, including relevant physical-health measurements such as pulse, blood pressure, height and weight.
What can you do while waiting?
Being on a medication waiting list does not mean that every other form of support must be placed on hold. Meaningful support can begin before, alongside or instead of medication.
Support may include:
- ADHD-focused psychoeducation.
- Understanding strengths and support needs.
- Executive-function strategies.
- Planning and organisation support.
- Sleep and routine interventions.
- Emotional-regulation support.
- ADHD-informed psychological therapy.
- Parent or family support.
- Workplace or educational adjustments.
- Support for coexisting mental-health needs.
It can also be helpful to maintain an up-to-date record of current medication, physical-health conditions and any changes in mental health while waiting. Completing requested questionnaires and medical investigations promptly may help prevent avoidable delays.
Speak to your GP or referring service if your physical or mental health changes significantly. Urgent or crisis needs should not wait for an ADHD medication appointment.
Medication and therapy are not competing approaches
Medication can be beneficial for some people, but it may not address every emotional, social or practical effect of living with ADHD.
A person may experience improved concentration or impulse control while continuing to require support with:
- Emotional regulation.
- Relationships and communication.
- Anxiety or depression.
- Trauma-related experiences.
- Self-esteem and identity.
- Work, education or parenting.
- Habits and coping strategies developed before diagnosis.
Depending on individual needs and clinical suitability, support might involve medication, psychosocial intervention, therapy, environmental changes or a combination of approaches.
A more connected approach
Lycali’s developing integrated pathway
At Lycali, we believe ADHD care should extend beyond the diagnostic report. We are developing an integrated pathway bringing together diagnostic assessment, medication management, psychosocial assessment and therapeutic intervention.
Depending on individual needs, the planned pathway may include:
- Medication assessment and titration where clinically appropriate.
- Psychoeducation and practical post-diagnostic support.
- Psychosocial assessment and collaborative treatment planning.
- ADHD-informed psychological intervention.
- Support for associated anxiety, depression, trauma and emotional-regulation needs.
- Review of progress using clinically appropriate outcome measures.
- Communication with GPs, families and other professionals, with consent.
Medication may form one part of the pathway, while therapy and psychosocial support address the wider emotional, relational and functional impact of living with ADHD.
A diagnosis should open the door to support
A long medication waiting list can feel particularly difficult after someone has already waited for an ADHD assessment. However, medication is not the only meaningful next step.
The period after diagnosis can be used to understand individual needs, introduce practical adjustments, strengthen emotional wellbeing and develop a more holistic support plan.
The strongest pathway is not necessarily medication or therapy alone. It is one in which the different elements of care work together around the person.
Looking for support after an ADHD diagnosis?
Contact Lycali to discuss our current ADHD assessment and post-diagnostic support services and to register your interest in our developing integrated pathway.
Contact Lycali